Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High-Field Postmortem MRI a Feasible and Less Invasive Alternative to Conventional Fetal Autopsy

By LabMedica International staff writers
Posted on 26 Aug 2009
Whole-body high-field magnetic resonance imaging (MRI) is an effective alternative to postmortem examination of human fetuses and may provide a less invasive option for traditional autopsy.

Examination after death can provide important information about why a fetus did not survive and help to evaluate the accuracy of diagnostic methods in utero and the risk to future pregnancies. More...
This information is chiefly obtained from autopsies. However, over the past decade--after incidents raised public suspicion about autopsies--there has been a considerable decline in the number of parents agreeing to an autopsy. This has prompted research into less invasive methods of postmortem.

Conventional whole-body MRI at 1.5 T was thought to offer the most practical alternative, but have been shown to provide inadequate image quality of small fetuses. In contrast, high-field (9.4 T) whole-body MRI provides good images and has shown promising results in small animals, but has not been performed in humans.

Dr. Sudhin Thayyil, from UCL Institute of Child Health and Great Ormond Street Hospital (London, UK), and colleagues examined the feasibility of high-field MRI and compared the diagnostic usefulness of high-field MRI with conventional MRI and traditional invasive autopsy in small human fetuses.

Whole-body MRI at 9.4 T and 1.5 T was performed on 18 fetuses of less than 22 weeks' gestation before doing a conventional invasive autopsy. Images from the MRI were compared with the findings of invasive autopsy in a blinded manner and assessed for diagnostic accuracy and image quality by a team of specialist pediatric radiologists.

Overall, traditional invasive autopsy did not provide superior diagnostic accuracy compared to high-field MRI in any of the examinations, and in some cases, the high-field MRI provided more information than the invasive autopsy. Spatial resolution, tissue contrast, and image quality for all organ systems were much better with high-field MRI than with conventional MRI. Moreover, all structural abnormalities detected by traditional invasive autopsy and internal examination of visceral organs were also detected with high-field MRI. In contrast, conventional MRI was found not diagnostically useful in 78% of cases.

The investigators, who published their study's findings in the August 8, 2009, issue of the Lancet, stated, "In the future specialist pathologists might be able to offer a two-stage postmortem process to parents, whereby an MRI at 9.4 T plus information from all other noninvasive tests…is done first, and then, if needed, a targeted internal examination of the body is done [minimally invasive autopsy]. Alternatively, this form of autopsy might be offered to parents who refuse conventional autopsy…such an approach might increase autopsy rates and bring back postmortem research in the UK.”

However, the researchers cautioned that these are very early data and further evidence from large prospective studies is required before minimally invasive autopsy can be offered routinely in clinical practice.

In an accompanying comment in the same issue of Lancet, Dr. Elspeth Whitby from the University of Sheffield (UK) and Dr. Marta Cohen from Sheffield Children's Hospital, (UK) highlight several practical problems that they reported that need to be addressed if postmortem MRI is to have a significant role in the future. These include limited access to MRI scanners, a service already stretched in the United Kingdom; and availability of specialists to perform the scans and interpret the images when there is already a worldwide shortage of radiologists.

Related Links:
UCL Institute of Child Health and Great Ormond Street Hospital




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.